GB9009549D0 - Recombinant antibody and method - Google Patents
Recombinant antibody and methodInfo
- Publication number
- GB9009549D0 GB9009549D0 GB909009549A GB9009549A GB9009549D0 GB 9009549 D0 GB9009549 D0 GB 9009549D0 GB 909009549 A GB909009549 A GB 909009549A GB 9009549 A GB9009549 A GB 9009549A GB 9009549 D0 GB9009549 D0 GB 9009549D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- recombinant antibody
- recombinant
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909009549A GB9009549D0 (en) | 1990-04-27 | 1990-04-27 | Recombinant antibody and method |
CA002081478A CA2081478A1 (en) | 1990-04-27 | 1991-04-29 | Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
JP3509384A JPH06500229A (ja) | 1990-04-27 | 1991-04-29 | 擬人化cdr移植抗icam―1抗体、その生産方法及びその使用 |
EP19910910051 EP0528951A4 (en) | 1990-04-27 | 1991-04-29 | Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
AU79001/91A AU7900191A (en) | 1990-04-27 | 1991-04-29 | Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
HU923371A HUT62652A (en) | 1990-04-27 | 1991-04-29 | Process for producing humqnized cdr-inoculated anti-icam-1 antibodies |
BR919106392A BR9106392A (pt) | 1990-04-27 | 1991-04-29 | Anticorpos anti-icam-1 enxertados-cdr humanizados,metodos de preparacao e uso dos mesmos |
PCT/US1991/002942 WO1991016927A1 (en) | 1990-04-27 | 1991-04-29 | Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
NO92924087A NO924087L (no) | 1990-04-27 | 1992-10-22 | Antistoffer, fremgangsmaate for deres fremstilling og anvendelse dera |
FI924818A FI924818A0 (fi) | 1990-04-27 | 1992-10-23 | Cdr-ympade anti-icam-1-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning |
HU9203371A HU9203371D0 (en) | 1990-04-27 | 1992-10-27 | Humanized cdr-grafted anti-icam-1 antibodies and method for producing them5 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909009549A GB9009549D0 (en) | 1990-04-27 | 1990-04-27 | Recombinant antibody and method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9009549D0 true GB9009549D0 (en) | 1990-06-20 |
Family
ID=10675134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB909009549A Pending GB9009549D0 (en) | 1990-04-27 | 1990-04-27 | Recombinant antibody and method |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0528951A4 (hu) |
JP (1) | JPH06500229A (hu) |
AU (1) | AU7900191A (hu) |
BR (1) | BR9106392A (hu) |
CA (1) | CA2081478A1 (hu) |
GB (1) | GB9009549D0 (hu) |
HU (2) | HUT62652A (hu) |
WO (1) | WO1991016927A1 (hu) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
GB9009548D0 (en) * | 1990-04-27 | 1990-06-20 | Celltech Ltd | Chimeric antibody and method |
EP0459577A3 (en) * | 1990-06-01 | 1992-08-05 | Merck & Co. Inc. | Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors |
US5686582A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US5686581A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
US5223396A (en) * | 1991-05-03 | 1993-06-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for detecting organ transplant rejection |
AU667487B2 (en) * | 1991-10-01 | 1996-03-28 | General Hospital Corporation, The | Preventing allograft rejection with antibodies to adhesion molecules |
US5635177A (en) | 1992-01-22 | 1997-06-03 | Genentech, Inc. | Protein tyrosine kinase agonist antibodies |
ES2112431T3 (es) * | 1992-08-21 | 1998-04-01 | Genentech Inc | Procedimiento para el tratamiento de un trastorno mediado por lfa-1. |
US5844094A (en) * | 1992-09-25 | 1998-12-01 | Commonwealth Scientific And Industrial Research Organization | Target binding polypeptide |
US5484892A (en) * | 1993-05-21 | 1996-01-16 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells |
US5695760A (en) * | 1995-04-24 | 1997-12-09 | Boehringer Inglehiem Pharmaceuticals, Inc. | Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation |
US5914112A (en) * | 1996-01-23 | 1999-06-22 | Genentech, Inc. | Anti-CD18 antibodies in stroke |
US20020081294A1 (en) | 1996-01-23 | 2002-06-27 | Genentech, Inc. | Co-administration of a thrombolytic and an anti-CD18 antibody in stroke |
US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
US20030035798A1 (en) | 2000-08-16 | 2003-02-20 | Fang Fang | Humanized antibodies |
US6670321B1 (en) | 1998-12-30 | 2003-12-30 | The Children's Medical Center Corporation | Prevention and treatment for retinal ischemia and edema |
US6582698B1 (en) | 1999-03-19 | 2003-06-24 | Genentech, Inc. | Treatment method |
DK1163003T3 (da) | 1999-03-19 | 2009-11-30 | Genentech Inc | Behandling af LFA-1 associerede lidelser med ögende doser af LFA-1-antagonist |
CA2377479C (en) | 1999-06-24 | 2011-01-11 | Richard B. Markham | Compositions and methods for preventing transepithelial transmission of hiv |
ATE353913T1 (de) | 2000-04-21 | 2007-03-15 | Fuso Pharmaceutical Ind | Neue collectine |
NZ535425A (en) * | 2002-03-13 | 2008-05-30 | Biogen Idec Inc | Anti-alphavbeta6 antibodies |
MXPA06014354A (es) | 2004-06-09 | 2007-02-19 | Genentech Inc | Metodo para tratar granuloma anular o sarcoide. |
CN104072614B (zh) | 2005-07-08 | 2017-04-26 | 生物基因Ma公司 | 抗-αvβ6 抗体及其用途 |
ES2602781T3 (es) * | 2011-07-05 | 2017-02-22 | Dinona Inc. | Un anticuerpo que induce tolerancia de linfocitos T específica de antígeno y uso del mismo |
WO2014143739A2 (en) | 2013-03-15 | 2014-09-18 | Biogen Idec Ma Inc. | Anti-alpha v beta 6 antibodies and uses thereof |
WO2014144466A1 (en) | 2013-03-15 | 2014-09-18 | Biogen Idec Ma Inc. | Anti-alpha v beta 6 antibodies and uses thereof |
KR102063341B1 (ko) * | 2018-12-31 | 2020-01-07 | 다이노나(주) | Icam-1에 특이적으로 결합하는 항체 및 그의 용도 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8720833D0 (en) * | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
DE3852374T2 (de) * | 1987-11-02 | 1995-05-04 | Baylor College Medicine | Verwendung von ICAM-1 oder ihre funktionelle Derivate zur Behandlung unspezifischer Entzündungen. |
-
1990
- 1990-04-27 GB GB909009549A patent/GB9009549D0/en active Pending
-
1991
- 1991-04-29 CA CA002081478A patent/CA2081478A1/en not_active Abandoned
- 1991-04-29 HU HU923371A patent/HUT62652A/hu unknown
- 1991-04-29 WO PCT/US1991/002942 patent/WO1991016927A1/en not_active Application Discontinuation
- 1991-04-29 EP EP19910910051 patent/EP0528951A4/en not_active Withdrawn
- 1991-04-29 JP JP3509384A patent/JPH06500229A/ja active Pending
- 1991-04-29 BR BR919106392A patent/BR9106392A/pt not_active Application Discontinuation
- 1991-04-29 AU AU79001/91A patent/AU7900191A/en not_active Withdrawn
-
1992
- 1992-10-27 HU HU9203371A patent/HU9203371D0/hu unknown
Also Published As
Publication number | Publication date |
---|---|
EP0528951A1 (en) | 1993-03-03 |
JPH06500229A (ja) | 1994-01-13 |
EP0528951A4 (en) | 1993-05-26 |
AU7900191A (en) | 1991-11-27 |
HUT62652A (en) | 1993-05-28 |
WO1991016927A1 (en) | 1991-11-14 |
CA2081478A1 (en) | 1991-10-28 |
HU9203371D0 (en) | 1993-01-28 |
BR9106392A (pt) | 1993-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9009549D0 (en) | Recombinant antibody and method | |
HU9303026D0 (en) | New antibodies and their application | |
IL111926A0 (en) | Humanized antibodies and uses thereof | |
GB9415380D0 (en) | Recombinant antibodies specific for tnf- | |
GB9013410D0 (en) | Polypeptide and its use | |
EP0451848A3 (en) | Immunoassay element and process for immunoassay | |
IL87730A0 (en) | Peptides and antibodies | |
EP0285511A3 (en) | Monoclonal antibodies and their uses | |
GB9023145D0 (en) | Device and method | |
IL94141A0 (en) | Laser-warning method and laser-warning arrangement | |
ZA907279B (en) | Antibodies and proteins | |
GB9000802D0 (en) | Bonding method and assembly for use therein | |
EP0458475A3 (en) | Transpeptidation reagent and method | |
GB9223676D0 (en) | Modified antibodies | |
GB9021777D0 (en) | Device and method | |
GB9026896D0 (en) | Method and composition | |
AU1304892A (en) | Retaining method and means | |
GB9225262D0 (en) | Recombinant antibody molecules and method | |
GB9004634D0 (en) | An antibody and use thereof | |
GB9106568D0 (en) | Recombinant antigen | |
IE892973L (en) | Antigen and immunodiagnostic method | |
GB8919485D0 (en) | Novel antibody and preparative method therefor | |
GB9210944D0 (en) | Monoclonal antibodies and their use | |
GB9210930D0 (en) | Monoclonal antibodies and their use | |
GB9210929D0 (en) | Monoclonal antibodies and their use |